Our Science · OrthoBio Division

OrthoBio Division, a new standard.

A first-of-its-kind department dedicated entirely to advancing the science, application and study of orthobiologics and regenerative musculoskeletal medicine.

Our Approach

Not a Service Line, a strategic evolution.

Musculoskeletal conditions have long followed a familiar playbook: manage symptoms, delay decline and, eventually, operate. OrthoBio was built on a different premise. It integrates our umbilical cord–derived mesenchymal stem cells (hUC-MSCs) with precision orthopedic protocols, and turns every patient encounter into an opportunity to learn, refine and contribute to the evidence.

Precision orthopedic protocolsCondition-specific, often ultrasound-guided
Auracells™ under AABB accreditationValidated, traceable biologics from our own laboratory
Outcomes tracked and publishedResearch that moves the field forward
Dr. Christian Díaz examining a patient’s foot in a treatment room overlooking Panamá City

Leadership

Clinical Excellence,forward-thinking medicine.

OrthoBio is led by two physicians at the intersection of orthopedic expertise and regenerative science.

Dr. Christian Díaz
Medical DirectorDr. Christian DíazInstrumental in shaping Auragens’ clinical philosophy, safety protocols and treatment frameworks across every specialty.
Read full bio +

Dr. Díaz’s career spans hospital medicine, reproductive care, intensive care and translational research. At Auragens he serves as Medical Director, leading the development and clinical execution of evidence-based regenerative protocols that adhere to international safety and regulatory standards. His academic work through Johns Hopkins University centers on immunomodulation and the clinical impact of human umbilical cord–derived MSCs. His goal is to accelerate safe, accessible, next-generation therapies for patients in Panamá and beyond.

Areas of Expertise

  • Mesenchymal stromal cell (MSC) therapy and biologics
  • Regenerative medicine protocols for pain, inflammation and women’s health
  • Precision and longevity-focused medicine
  • Exosome-based therapeutics
  • Clinical research design and evidence-based practice

Education & Certifications

  • Master of Science, Regenerative & Stem Cell Technologies, Johns Hopkins University
  • Medical Degree, Medicine & Surgery, Universidad Latina de Panamá
  • BSc Biology / Pre-Medical Studies, Baylor University, Texas
  • General Practitioner License, MINSA, Panamá
  • Medical degree equivalency recognized in Colombia and Spain

Professional Highlights

  • Medical Director of the Auragens Center for Regenerative Medicine
  • National and international speaker on regenerative medicine and cellular therapies
  • First-author publication on MSCs for chronic lumbar pain (2024)
  • Among the first formally trained physicians advancing cellular therapies in Panamá

Personal Note

Dr. Díaz is passionate about the intersection of lifestyle, biology and longevity. He believes regenerative medicine should be at the forefront of modern medical specialties, empowering patients to restore function and quality of life through innovative, patient-centered science.

Dr. Abdiel Ortiz
Head of OrthoBioDr. Abdiel OrtizAn accomplished orthopedic and trauma surgeon who brings deep expertise in musculoskeletal pathology, procedural precision and clinical outcomes.
Read full bio +

With a foundational background as a physiotherapist before completing his orthopedic training, Dr. Ortiz brings a deep understanding of biomechanics, functional recovery and long-term joint health, and extensive experience in high-complexity surgical centers. At Auragens, he manages shoulder, knee, hip and elbow conditions, integrating advanced orthopedic techniques with regenerative therapies, and leads the physiotherapy and rehabilitation protocols that align orthopedic care with functional restoration.

Areas of Expertise

  • Musculoskeletal degenerative diseases
  • Sports injuries
  • Physical rehabilitation protocols
  • Minimally invasive biological cellular therapies and surgical biological augmentation
  • Clinical research design and evidence-based practice

Education & Certifications

  • Medical Degree, Medicine & Surgery, Universidad Latina de Panamá
  • Master’s Degree, Orthopedic and Trauma Specialist, Universidad de Panamá / Caja de Seguro Social
  • BSc in Physical Therapy, Universidad Latina de Panamá
  • Postgraduate in Sports Medicine, Hospital Perpetuo Socorro, Gran Canaria, Spain (ISAKOS Teaching Center)
  • Internship in Sports Medicine, Clínica Alemana – Universidad del Desarrollo, Santiago de Chile

Professional Highlights

  • National and international speaker on regenerative medicine and cellular therapies
  • Academic excellence awards in Orthopedics and Traumatology Residency and in Physiotherapy

Personal Note

As a healthcare professional and athlete, Dr. Ortiz leads by example. He believes in biological healing and physiology, applying these principles in his daily life and with every patient.

Where Clinical Medicine Meets Discovery

The Questions,that move the field forward.

OrthoBio’s mission extends beyond treating injuries. Every patient encounter is a chance to learn, improve and contribute to the evidence behind regenerative medicine.

01Which biologics perform best for specific conditions?
02How can treatment protocols be refined?
03What imaging findings predict success?
04How do cellular therapies integrate into modern orthopedic practice?

Research & Results

Excellence,leaves evidence.

OrthoBio physicians have presented research at international conferences, collaborated with experts across the Americas, Europe and Asia, and published their findings for the scientific community.

New Publication · Cureus, October 2026Nonoperative Management of an Acute Complete Achilles Tendon Rupture With Mesenchymal Stem Cells and Extracellular Vesicles: A Case ReportOrtiz A, Diaz C. Cureus 18(10): e118122. DOI 10.7759/cureus.118122. A single, hypothesis-generating case by the OrthoBio and Advanced Cellular Therapies teams.
Read on Cureus

In-house case series · Professional athletes · Knee osteoarthritis

7 of 10knees met the clinically meaningful threshold on the KOOS score
10 of 10knees improved over baseline on the KOOS composite
0serious adverse events reported

Díaz C, Ortíz A. Single-center case series of 7 patients (10 knees), May 2025 – May 2026, with mixed follow-up, no control group and significant loss to follow-up; hypothesis-generating, not a controlled efficacy claim. Individual results vary.

Science, Safety & Experience

One Foundation,every protocol.

OrthoBio draws on the same foundation as all of Auragens: biologics produced in an FDA-registered laboratory under AABB accreditation, validated by third-party laboratories and governed by rigorous quality standards.

Advanced cell sourcing & processingStrict safety & sterility protocolsPersonalized treatment designIntegrated care from arrival through recovery
The Auragens team working in the cleanroom laboratory

OrthoBio FAQs

Your Questions, answered with care.

What are orthobiologics?

Orthobiologics are biological substances, such as cells and the factors they release, used to support the healing of bones, cartilage, tendons, ligaments and muscles. At Auragens, they are built around our umbilical cord–derived mesenchymal stem cells and their extracellular vesicles.

Who leads the OrthoBio Division?

Medical Director Dr. Christian Díaz and Head of OrthoBio Dr. Abdiel Ortiz, an orthopedic and trauma surgeon, together with our interdisciplinary clinical and scientific team.

Which conditions does OrthoBio evaluate?

Ligament and tendon injuries, cartilage and joint degeneration, spinal conditions and chronic musculoskeletal inflammation, for professional athletes and active adults alike. Candidacy is always determined by medical review.

Is this an alternative to surgery?

Not in every case. Some injuries require surgical care. For patients exploring non-surgical options, our team reviews your imaging and history and discusses whether a regenerative protocol may be appropriate, alongside your own physicians.

Is stem cell therapy approved by the FDA?

Mesenchymal stem cell therapy is investigational for most musculoskeletal conditions and is not approved by the U.S. Food and Drug Administration as a standard treatment for them. Our team presents the current evidence, including its limitations, to every patient.

Can physicians refer patients or collaborate on research?

Yes. Physicians, surgeons and researchers are welcome to contact us about referrals, our protocols or research collaboration.

How to Get Started

Ready to See If Auragens is right for you?

Start with a candidacy review — no commitment required to find out where you stand.

Contact Us